Literature DB >> 15705358

Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression.

Vjera A Holthoff1, Bettina Beuthien-Baumann, Elke Kalbe, Susanne Lüdecke, Olaf Lenz, Gerhard Zündorf, Sebastian Spirling, Kristin Schierz, Peter Winiecki, Sandro Sorbi, Karl Herholz.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is clinically characterized by cognitive impairment and behavioral disturbances. The aim of the study was to identify regional alterations in brain function associated with neuropsychiatric symptoms in early AD.
METHODS: Patients underwent measures of cerebral glucose metabolism applying positron emission tomography (PET) and (18)F-fluorodeoxyglucose. Neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory (NPI). Positron emission tomography images of patients suffering a neuropsychiatric symptom of clinical significance (NPI subscore for a specific item >/=4 points) were compared with the images of patients without the specific symptom under study (NPI subscore for a specific item = 0 points).
RESULTS: A total of 53 patients with AD (Mini-Mental State Examination [MMSE] 22.5 +/- 2.94 points) entered the study. Of all symptoms, apathy and depression were most frequently encountered. The patient group with apathy (n = 17) revealed significant decreases in left orbitofrontal regions when compared with patients free of apathy. Depression of clinical significance (n = 10) was associated with hypometabolism in dorsolateral prefrontal regions.
CONCLUSIONS: These findings support the notion that different functional circuits underlie apathy and depression in early AD.

Entities:  

Mesh:

Year:  2005        PMID: 15705358     DOI: 10.1016/j.biopsych.2004.11.035

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  42 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

3.  Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence.

Authors:  Jose J Miguel-Hidalgo; James C Overholser; Herbert Y Meltzer; Craig A Stockmeier; Grazyna Rajkowska
Journal:  Alcohol Clin Exp Res       Date:  2006-11       Impact factor: 3.455

4.  Optimization of the SNR-resolution tradeoff for registration of magnetic resonance images.

Authors:  Shoan C Kale; Jason P Lerch; R Mark Henkelman; X Josette Chen
Journal:  Hum Brain Mapp       Date:  2008-10       Impact factor: 5.038

Review 5.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

Review 6.  Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?

Authors:  Andrew H Ford; Osvaldo P Almeida
Journal:  Drugs Aging       Date:  2017-02       Impact factor: 3.923

7.  Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.

Authors:  Matthias Brendel; Oliver Pogarell; Guoming Xiong; Andreas Delker; Peter Bartenstein; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-29       Impact factor: 9.236

8.  The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults.

Authors:  Lauren A Rog; Lovingly Quitania Park; Danielle J Harvey; Chun-Jung Huang; Scott Mackin; Sarah Tomaszewski Farias
Journal:  Clin Neuropsychol       Date:  2014-02-06       Impact factor: 3.535

9.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

10.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.